New biomarkers in the eyes could unlock the key to management of diabetic retinopathy
New biomarkers found in the eyes could unlock the key to helping manage diabetic retinopathy, and perhaps even diabetes, according to new research conducted at the Indiana University School of Optometry.
During its early stages, diabetes can affect the eyes before the changes are detectable with a regular clinical examination. However, new retinal research has found that these changes can be measured earlier than previously thought with specialized optical techniques and computer analysis.
The ability to detect biomarkers for this sight-threatening condition may lead to the early identification of people at risk for diabetes or a visual impairment, as well as improve physicians' ability to manage these patients. The study appears in the journal PLOS One.